Our Year in Review: Insights, outcomes, and highlights that shaped 2025. Read the full report!
Aligning Science Across Parkinson's Logo Text

ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress

Output Details

Recessive loss-of-function mutations in ATP13A2 (PARK9) are associated with a spectrum of neurodegenerative disorders, including Parkinson’s disease (PD). We recently revealed that the late endo-lysosomal transporter ATP13A2 pumps polyamines like spermine into the cytosol, whereas ATP13A2 dysfunction causes lysosomal polyamine accumulation and rupture. Here, we investigate how ATP13A2 provides protection against mitochondrial toxins such as rotenone, an environmental PD risk factor. Rotenone promoted mitochondrial-generated superoxide (MitoROS), which was exacerbated by ATP13A2 deficiency in SH-SY5Y cells and patient-derived fibroblasts, disturbing mitochondrial functionality and inducing toxicity and cell death. Moreover, ATP13A2 knockdown induced an ATF4-CHOP-dependent stress response following rotenone exposure. MitoROS and ATF4-CHOP were blocked by MitoTEMPO, a mitochondrial antioxidant, suggesting that the impact of ATP13A2 on MitoROS may relate to the antioxidant properties of spermine. Pharmacological inhibition of intracellular polyamine synthesis with α-difluoromethylornithine (DFMO) also increased MitoROS and ATF4 when ATP13A2 was deficient. The polyamine transport activity of ATP13A2 was required for lowering rotenone/DFMO-induced MitoROS, whereas exogenous spermine quenched rotenone-induced MitoROS via ATP13A2. Interestingly, fluorescently labeled spermine uptake in the mitochondria dropped as a consequence of ATP13A2 transport deficiency. Our cellular observations were recapitulated in vivo, in a Caenorhabditis elegans strain deficient in the ATP13A2 ortholog catp-6. These animals exhibited a basal elevated MitoROS level, mitochondrial dysfunction, and enhanced stress response regulated by atfs-1, the C. elegans ortholog of ATF4, causing hypersensitivity to rotenone, which was reversible with MitoTEMPO. Together, our study reveals a conserved cell protective pathway that counters mitochondrial oxidative stress via ATP13A2-mediated lysosomal spermine export.
Identifier (DOI)
10.1073/pnas.1922342117
Tags
  • ATP13A2
  • Lysosomal dysfunction
  • Mitochondria
  • Original Research
  • Polyamine

Meet the Authors

  • Stephanie Vrijsen, MSc

    Key Personnel: Team Vangheluwe

    KU Leuven

  • User avatar fallback logo

    laura Besora-Casals

    External Collaborator

  • Sarah van Veen, PhD

    Key Personnel: Team Vangheluwe

    KU Leuven

  • User avatar fallback logo

    Jeffrey Zielich

    External Collaborator

  • Chris Van den Haute, PhD

    Key Personnel: Team Vangheluwe

    KU Leuven

  • User avatar fallback logo

    Norin Hamouda

    External Collaborator

  • User avatar fallback logo

    Christian Fischer

    External Collaborator

  • User avatar fallback logo

    Bart Ghesquière

    External Collaborator

  • User avatar fallback logo

    Ivailo Tournev

    External Collaborator

  • User avatar fallback logo

    Patrizia Agostinis

    External Collaborator

  • Veerle Baekelandt, PhD

    Co-PI (Core Leadership): Team Vangheluwe

    KU Leuven

  • User avatar fallback logo

    Jan Eggermont

    External Collaborator

  • User avatar fallback logo

    Eric Lambie

    External Collaborator

  • User avatar fallback logo

    Shaun Martin

    External Collaborator

  • Peter Vangheluwe, PhD

    Lead PI (Core Leadership): Team Vangheluwe

    KU Leuven

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.